Status:
COMPLETED
Single Dose Bronchodilatory Study in Asthma
Lead Sponsor:
Cornerstone Therapeutics Inc.
Conditions:
Asthma
Eligibility:
All Genders
18-55 years
Phase:
PHASE4
Brief Summary
Study to evaluate the bronchodilator effects of Zyflo CR in patients with chronic stable asthma.
Eligibility Criteria
Inclusion
- Diagnosis of asthma for at least 5 years
- FEV1 of 50-85% predicted
- Reversible airway obstruction
Exclusion
- Pregnant/nursing females
- Liver function tests greater than upper limit of normal
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01805687
Start Date
March 1 2013
Last Update
September 3 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northeast Medical Research Associates
North Dartmouth, Massachusetts, United States, 02747